KYOWA KIRIN
Kyowa Hakko Kirin Co is a Japanese pharmaceutical and biotechnology company that specializes in healthcare.
KYOWA KIRIN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1949-07-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.kyowakirin.com
Total Employee:
11+
Status:
Active
Contact:
81 3-5205-7200
Technology used in webpage:
LetsEncrypt WordPress Font Awesome Apache Wordpress Plugins Mobile Non Scaleable Content Organization Schema Yoast WordPress SEO Plugin ReCAPTCHA Yoast SEO Premium
Similar Organizations
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Wockhardt Hospitals
Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.kyowakirin.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.51 K
- Host name: ec2-18-179-126-206.ap-northeast-1.compute.amazonaws.com
- IP address: 18.179.126.206
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Kyowa Kirin"
Kyowa Kirin Announces Changes to its Organization
Kyowa Kirin Announces Changes to its Organization Tokyo, Japan, August 26, 2022 – Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto, “Kyowa Kirin”, TSE: 4151) announced …See details»
Corporate Governance | Management | Investors
Mar 19, 2025 Introduction of Corporate Governance. The Company is carrying out its business activities ba sed on a philosophy that “ The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around …See details»
Kyowa Kirin - Wikipedia
Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 …See details»
Kyowa Kirin Announces Changes in Top Leadership Positions to …
Oct 31, 2024 Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030 Vision and …See details»
Kyowa Kirin Integrates North America Businesses in Support of …
Mar 31, 2021 The outcome of this merger is a simpler business structure for the organization and a common set of processes and systems to enhance the productivity and collaborations …See details»
Kyowa Kirin Canada | Kyowa Kirin North America
By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, …See details»
Top | Investors | Kyowa Kirin Co., Ltd.
Mar 10, 2025 Introduction of Kyowa Kirin Co., Ltd. Investor Relations.See details»
Kyowa Kirin International - About
May 14, 2024 At Kyowa Kirin International, "Commitment to Life" is at our core. With over 500 people focused on this purpose we've become a highly successful and rapidly growing …See details»
Kyowa Kirin | Specialty Pharmaceuticals for Global …
Making People Smile For Generations To Come. Kyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug …See details»
Kyowa Kirin Announces Changes to its Organization
Miyamoto, “Kyowa Kirin”, TSE: 4151) announced that it will make changes to its organization as of April 1, 2021. Outline of the changes: 1) Strategic Product Planning Department will be split …See details»
Kyowa Kirin Announces its Organizational Change
Organization as of July 1, 2021. Outline of the change: R&D Quality Assurance Department will be newly established within the Quality Division. Purpose of the organizational change: By …See details»
Kyowa Kirin: 70+ Years of Innovation in Pharmaceuticals
Kyowa Kirin: Advancing healthcare for over 70 years. Discover our commitment to under-served conditions, high-quality pharmaceuticals & bio-chemicals. Explore our global reach and values.See details»
Kyowa Kirin successfully completes acquisition of Orchard …
Sep 30, 2023 You can learn more about the business of Kyowa Kirin at: www.kyowakirin.com. About Orchard Therapeutics Orchard Therapeutics, a Kyowa Kirin company, is a global gene …See details»
Kyowa Kirin CEO Miyamoto’s New Year Message: Accelerate Our …
Jan 14, 2025 The research organization began a fresh chapter with a new structure in January this year. This change was made to enhance the integration of expertise and resources …See details»
Kyowa Kirin - Overview, News & Similar companies - ZoomInfo
Apr 11, 2023 View Kyowa Kirin (kkna.kyowakirin.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Kyowa Kirin North America Homepage, a Specialty Pharmaceutical …
Kyowa Kirin pursues scientific breakthroughs to address unmet clinical needs. Learn more about our portfolio of specialty medicines in nephrology, oncology, immunology & allergy, and …See details»
Product Quality Associate - LinkedIn
Mar 24, 2025 Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease …See details»
Corporate History｜Yakult 90th Anniversary Website
Yakult Honsha is certified as a ‘Certified Health & Productivity Management Organization – White 500' (first year). Yakult is certified for the eighth consecutive year in 2025. Yakult Five is …See details»
Learn How Our Values Help Drive Global Pharmaceutical …
Prior to joining this organization, she was Vice President and Head Global Medical Affairs at Ventana/Roche Tissue Diagnostics. She is a physician with 10 years experience in clinical …See details»
What is the Kyowa Kirin Group’s health and productivity …
Feb 10, 2025 To accomplish this, we will implement initiatives designed to cultivate an organization where healthy and diverse talent can thrive and drive innovation. Corporate …See details»